MarketScreener Editorial Features Taiwan Bio Therapeutics Co., Ltd

Equities

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
52.6 ^TWD	-4.54%		+28.14%	+53.35%

Mar. 12	TRACT Therapeutics and Taiwan Bio Therapeutics Announce to Launch Phase 2 Clinical Trial Investigating Ability of Treg Therapy to Reduce Use of Immunosuppressant Drugs in Living Donor Kidney Transplant Recipients	CI
2023	Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant	CI

No results for this search